🇺🇸 FDA
Patent

US 9486474

Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

granted A61KA61K31/167A61K31/24

Quick answer

US patent 9486474 (Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis) held by The Regents of the University of California expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/167, A61K31/24, A61K31/445, A61K31/727